​

Immuneering (IMRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Immuneering Revenue Highlights

0

Latest Revenue (Q)

$360.96K

Immuneering Revenue by Period

Immuneering Revenue by Year

DateRevenueChange
2025-12-31-100.00%
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$316.95K-84.76%
2021-12-31$2.08M-10.02%
2020-12-31$2.31M20.41%
2019-12-31$1.92M-

Immuneering generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Immuneering Revenue by Quarter

DateRevenueChange
2026-06-30$360.96K100.00%
2026-03-31-100.00%
2025-12-31-100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$455.00-98.81%
2022-09-30$38.38K-59.35%
2022-06-30$94.42K-48.60%
2022-03-31$183.70K-3.11%
2021-12-31$189.59K-60.68%
2021-09-30$482.13K-26.95%
2021-06-30$660.04K-11.78%
2021-03-31$748.20K12.50%
2020-12-31$665.08K-2.56%
2020-09-30$682.57K41.96%
2020-06-30$480.83K-0.46%
2020-03-31$483.05K-

Immuneering generated $360.96K in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Immuneering Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARCTArcturus Therapeutics$82.03M$2.96M
ENTAEnanta Pharmaceuticals$65.32M$14.36M
FHTXFoghorn Therapeutics$30.91M$16.07M
TRDAEntrada Therapeutics$25.42M$898.00K
PYXSPyxis Oncology$13.86M-
HUMAHumacyte$2.04M$406.00K
IMRXImmuneering-$360.96K
ZURAZura Bio--
TNYATenaya Therapeutics-$1.11M
NAUTNautilus Biotechnolgy-$190.00K
ASMBAssembly Biosciences--

IMRX Revenue FAQ

What is Immuneering’s yearly revenue?

Immuneering's yearly revenue for 2025 was $0, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. IMRX's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022.

What is Immuneering’s quarterly revenue?

Immuneering's quarterly revenue for Q2 2026 was $360.96K, a 100.00% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a 100.00% increase from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). IMRX's quarterly revenue for Q4 2025 was $0, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Immuneering’s revenue growth rate?

Immuneering's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was -100.00%.